A paradigm shift in neutrophil adverse event grading: What now?
Lauren E Merz · 2025
Read A paradigm shift in neutrophil adverse event grading: What now? by Lauren E Merz (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12745037.txt.
Description
Lauren Merz wrote a 2025 commentary on a major change in how side effects are graded in cancer trials. The shared system, known as CTCAE, has been used since the 1980s to record how severe a harm is. Its sixth version, released in the summer of 2025, shifts the grades for low neutrophil counts by one level.
Merz explains why the shift was made and what it will mean for trials now running and still to come. One reason is fairness for people whose counts are naturally lower without higher risk of infection. The change also fits decades of data on when low counts truly raise concern. Trial teams must now handle reports under the new scale with care.
Catalog record
| CREATOR | Lauren E Merz |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 9 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |